Literature DB >> 9686746

A follow-up study of actigraphic measures in home-residing Alzheimer's disease patients.

J A Yesavage1, L Friedman, H C Kraemer, A Noda, D Wicks, D L Bliwise, J Sheikh, J Tinklenberg, V Zarcone.   

Abstract

This article reports cross-sectional and follow-up data with actigraphic measures of nocturnal sleep and rest/activity in 61 Alzheimer's disease (AD) patients as well as the relation of actigraphic measures to levels of behavioral disturbance across different stages of the disease. Over the course of approximately 1.5 years' follow-up, patients showed significant deterioration of nocturnal sleep parameters, but no significant change in rest/activity circadian rhythm parameters. There were also significant correlations among nocturnal sleep, rest/activity circadian rhythm, and behavioral disturbance measures, but only in relatively early stages of AD. It is argued that study of nocturnal sleep and circadian rhythm in relation to behavioral disturbance in AD requires longitudinal data and analyses that take into account the stage of disease at which patients are assessed.

Entities:  

Mesh:

Year:  1998        PMID: 9686746     DOI: 10.1177/089198879801100103

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  12 in total

Review 1.  REVIEW: Apathy diagnosis, assessment, and treatment in Alzheimer's disease.

Authors:  Philippe H Robert; Emmanuel Mulin; Patrick Malléa; Renaud David
Journal:  CNS Neurosci Ther       Date:  2010-10       Impact factor: 5.243

2.  Circadian clock gene polymorphisms and sleep-wake disturbance in Alzheimer disease.

Authors:  Jerome A Yesavage; Art Noda; Beatriz Hernandez; Leah Friedman; Jauhtai J Cheng; Jared R Tinklenberg; Joachim Hallmayer; Ruth O'hara; Renaud David; Philippe Robert; Elizabeth Landsverk; Jamie M Zeitzer
Journal:  Am J Geriatr Psychiatry       Date:  2011-07       Impact factor: 4.105

3.  Quality of care for depressed elders in post-acute care: variations in needs met through services.

Authors:  Enola Proctor; Nancy Morrow-Howell; Mi Jin Lee; Jessica Gledhill; Wayne Blinne
Journal:  J Behav Health Serv Res       Date:  2006-04       Impact factor: 1.505

Review 4.  Non-pharmacologic management of sleep disturbance in Alzheimer's disease.

Authors:  R David; J Zeitzer; L Friedman; A Noda; R O'Hara; P Robert; J A Yesavage
Journal:  J Nutr Health Aging       Date:  2010-03       Impact factor: 4.075

5.  Circadian Rhythm Sleep Disorder: Irregular Sleep Wake Rhythm Type.

Authors:  Phyllis C Zee; Michael V Vitiello
Journal:  Sleep Med Clin       Date:  2009-06-01

6.  Recommendations for ICT use in Alzheimer's disease assessment: Monaco CTAD Expert Meeting.

Authors:  P H Robert; A Konig; S Andrieu; F Bremond; I Chemin; P C Chung; J F Dartigues; B Dubois; G Feutren; R Guillemaud; P A Kenisberg; S Nave; B Vellas; F Verhey; J Yesavage; P Mallea
Journal:  J Nutr Health Aging       Date:  2013       Impact factor: 4.075

7.  A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.

Authors:  Clifford Singer; Rochelle E Tractenberg; Jeffrey Kaye; Kim Schafer; Anthony Gamst; Michael Grundman; Ronald Thomas; Leon J Thal
Journal:  Sleep       Date:  2003-11-01       Impact factor: 5.849

8.  Rest-activity and behavioral disruption in a patient with frontotemporal dementia.

Authors:  J Merrilees; E Hubbard; J Mastick; B L Miller; G A Dowling
Journal:  Neurocase       Date:  2009-09-07       Impact factor: 0.881

Review 9.  Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. An American Academy of Sleep Medicine review.

Authors:  Robert L Sack; Dennis Auckley; R Robert Auger; Mary A Carskadon; Kenneth P Wright; Michael V Vitiello; Irina V Zhdanova
Journal:  Sleep       Date:  2007-11       Impact factor: 5.849

10.  Measurement of Neuropsychiatric Symptoms in Clinical Trials Targeting Alzheimer's Disease and Related Disorders.

Authors:  Renaud David; Emmanuel Mulin; Patrick Mallea; Philippe H Robert
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.